Clay Siegall and Seattle Genetics

Many companies are advancing in their research on cancer. Seattle Genetics is one of those companies. It has been in the field since 1998. Clay Siegall was one of the co-founders in 1998, and currently, the company’s member of the Board of Directors, President, and CEO.

From the time when he began his biomedical study career, and now the Seattle Genetics, Chief Executive Officer of Seattle, Dr. Clay Siegall has had the enthusiasm to improve the lives people suffering from cancer. Dr. Siegall has worked very hard to lead the organization to countless advancement in the research on cancer and innovative patient cancer therapies.

Under Dr. Siegall’s leadership, the company became the first company to develop antibody-drug conjugates (ADCS) such as ADCETRIS, which was approved by the Food and Drug Administration agency in 2011. The impact of the drug has expanded globally, and it is being used in more than 60 countries in the world. His guidance in the ADC Development and continuous promotion has proven his dedication that the medical community desire to bring changes in the cancer therapy field in the future.

Despite being in the one of those leading in the cancer treatment field, he has shown his leadership skills in his ability to help Seattle Genetic company raise more than $ 1.2 billion both in private and public fundraising. The funds obtained from the fundraising have helped the company to continue its progress in cancer treatments using the most innovative technology. Dr. Siegall represents a leader who has not only scientific wisdom but also visionary skills to boost the development of science to new levels.

The medical and scientific communities have recognized his significant contribution by awarding him. For example, in 2013, he received the Alumnus of the Year Award in Computer, Math, and Natural Sciences from the University of Maryland. In 2012 he was awarded the Pacific Northwest Ernst & Young Entrepreneur.

Dr. Siegall does not show any signs of slowing down with his passion for leading the company to newer scientific achievements. He has received 15 patents but is still looking for new ways to help improve on medical research. He has published over 70 scientific articles whereby he shares his knowledge with others in the medical and scientific communities. Dr. Siegall goal is to find ways to improve medicine so that patients with cancer will no longer suffer from it.

Leave a Reply

Your email address will not be published. Required fields are marked *